Search results
Novavax (NASDAQ:NVAX) Trading 3.4% Higher
ETF DAILY NEWS· 6 hours agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) shot up 3.4% during trading on Wednesday . 1,132,956 shares changed hands during trading, a decline of 90% from the average session ...
Why Vaccine Stocks Rallied This Week | The Motley Fool
The Motley Fool· 2 hours agoShares of vaccine stocks Moderna (MRNA 0.42%), Novavax (NVAX -3.50%), and BioNTech SE (BNTX -3.23%)...
COVID’s New ‘FLiRT’ Variants—What To Know As Experts Fear Summer Surge
Forbes· 2 days agoNew coronavirus variants dubbed “FLiRT” are circulating the world and growing dominant in the U.S.,...
3 Things You Need to Know If You Buy Novavax Today | The Motley Fool
The Motley Fool· 2 days agoNovavax (NVAX 5.30%) stock has both soared and plummeted at times in recent years. Investors...
Novavax Unusual Options Activity For May 23 - Novavax (NASDAQ:NVAX)
Benzinga· 21 hours agoThe company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly ...
Better Buy: Inovio Pharmaceuticals vs. Novavax | The Motley Fool
The Motley Fool· 2 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of...
Why Novavax (NVAX) Stock Price Appreciated 14% on Monday
Zacks via Yahoo Finance· 3 days agoNovavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company....
The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom
InvestorPlace· 1 day agoNovavax (NASDAQ:NVAX) stock was among the laggards in the race for the vaccine against COVID-19....
Explainer-What are the FLiRT COVID variants and are they more contagious?
KFGO· 4 hours agoBy Michael Erman NEW YORK (Reuters) - The so-called FLiRT variants of SARS-CoV-2 coronavirus that...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 4 days agovaccine makers say that the Food and Drug Administration’s delay in designing this fall’s Covid-19 ...
